Iradimed Corp. (IRMD) Tops Q3 EPS by 7c

Iradimed Corp. (NASDAQ: IRMD) reported Q3 EPS of $0.43, $0.07 better than the analyst estimate of $0.36. Revenue for the quarter came in at $16.5 million versus the consensus estimate of $16.18 million.

For earnings history and earnings-related data on Iradimed Corp. (IRMD) click here.

You May Also Be Interested In

• Micron offers Taiwan workers up to 68-month bonuses as strike threat looms
• Premarket movers: Oracle surges on AI growth, ACV auctions jumps on $1.9B deal
• Investing.com’s stocks of the week